Palladia is an antiproliferative and antiandiogenic agent used to treat Patnaik grade II or III, cutaneous mast cell tumors in dogs.
This medication uses toceranic phosphate to combat the effects of these recurrent tumors and works on both tumors with and without regional lymph node involvement. Palladia can also be used as an alternative to chemotherapy for other various types of tumors, including melanomas, thyroid carcinomas, and more.
This bottle comes with 10mg 30 Tabs, 15mg 30 Tabs and 50mg 30 Tabs to ensure that adjusting your dog’s dosage based on their weight is a simple manner.
Treats Patnaik grade II or III recurrent, cutaneous mast cell tumors in dogs
Can be used as alternative to chemotherapy for other types of tumors
Available in three different dosages in singles doses or packs of 30
Dosage & Administration Always provide Client Information Sheet with prescription. Administer an initial dosage of 3.25 mg/kg (1.48 mg/lb) body weight, orally every other day. Dose reductions of 0.5 mg/kg (to a minimum dose of 2.2 mg/kg (1.0 mg/lb) every other day) and dose interruptions (cessation of PALLADIA for up to two weeks) may be utilized, if needed, to manage adverse reactions. Adjust dose based on approximately weekly veterinary assessments for the first 6 weeks and approximately every 6 weeks, thereafter. PALLADIA may be administered with or without food. Do not split tablets.